Experimental therapies and vaccines for Ebola and Marburg viruses focus of Academy meeting

Recent outbreaks of Ebola and Marburg virus infections in Africa have been characterized by two remarkable features they have been unusually sustained and have maintained extremely high fatality rates. These two features have underscored the need to expand our current understanding of these fatal hemorrhagic diseases and to accelerate progress towards protective vaccines and novel therapeutic strategies.

To present news on the latest developments in our understanding of the molecular biology, epidemiology and approaches to vaccine development for these acute hemorrhagic viruses, the New York Academy of Sciences' Emerging Infectious Diseases Discussion Group is sponsor ing a meeting, Ebola and Marburg Viruses--Perspective 2005 on Thursday, June 2 at 5 p.m. The event will take place at the New York Academy of Sciences headquarters at 2 East 63rd Street, New York.

Speakers and topics will include:

Christopher Basler, Mount Sinai School of Medicine
"Antagonism of the Host Interferon Response by Ebola Viruses."

Daniel Bausch, Tulane University School of Medicine
"Controlling Marburg and Ebola Hemorrhagic Fevers: Where We've Been and Where We Need to Go."

Thomas Geisbert, United States Army Medical Research Institute of Infectious Diseases
"Countermeasures Against Ebola Virus and Marburg Virus: Advances and Challenges."

For more information, please visit the meetings/conferences section of the nyas.org web site


Contact: Jennifer Tang
212-838-0230 x257
New York Academy of Sciences

Page: 1

Related medicine news :

1. Experimental gene therapy abolishes arthritis pain and lessens joint damage
2. Mayo Clinic research in cardiovascular disease presented at Experimental Biology 2007
3. Experimental flu vaccine appears promising in early tests
4. Experimental ragweed therapy offers allergy sufferers longer relief with fewer shots
5. Experimental medication kicks depression in hours instead of weeks
6. Experimental vaccine protects lab animals against several strains of H5N1
7. Experimental shingles vaccine proves effective in nationwide study
8. Future therapies for stroke may block cell death
9. Antifolate therapies found effective against certain type of malaria
10. Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer
11. A sweet step toward new cancer therapies

Post Your Comments:

(Date:8/7/2020)... ... August 07, 2020 , ... As part of their efforts to prioritize the ... The Bengtson Center team decided to temporarily suspend most in-person appointments, with the exception ... With the offices now open again, the leading plastic surgeons in Michigan —Dr. ...
(Date:8/7/2020)... ... August 07, 2020 , ... On ... Fee Schedule proposed rule for the 2021 calendar year. The proposal significantly impacts ... procedures they perform which help return patients suffering from joint disease to productive, ...
(Date:8/5/2020)... ... August 05, 2020 , ... Emotional ABCs , America’s ... to the inaugural list of Best Digital Tools for Teaching & Learning by ... resources that provide enhanced learning and curriculum development for school librarians and their ...
(Date:8/5/2020)... , ... August 05, 2020 , ... AdventHealth Carrollwood has ... safely reopening for class on Monday, August 12, 2020. AdventHealth provided the school with ... of COVID-19 in the classroom setting. , “We are taking extra steps in ...
(Date:8/5/2020)... (PRWEB) , ... August 05, 2020 , ... ... to loss of consciousness, seizures, prolonged length of hospital stay, or even death. ... study of insulin-treated patients with Type 2 diabetes to see if the use ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... July 31, 2020 , ... Member Care Solutions announced a deal with American ... operators the licensing of their cloud based membership management software platform. , “We are ... Our software is the perfect match for many reasons, but AFC’s need to quickly ...
(Date:7/22/2020)... ... 22, 2020 , ... TrialScope, the global leader in clinical ... Moderna to its growing customer roster. , TrialScope customers include 16 of the ... patient engagement and study recruitment. Collectively, TrialScope customers are responsible for more than ...
(Date:7/18/2020)... ... 17, 2020 , ... The Women’s Fund Miami-Dade has launched ... who are experiencing abuse know that services are available 24/7, and to encourage ... County’s Coordinated Victim’s Assistance Center (CVAC) helpline. Although there hasn’t been an overwhelming ...
Breaking Medicine Technology:
Cached News: